News
Introduction Computational drug design typically requires a well-defined protein-ligand complex.
Introduction The DARPA IMPAQT ARC Opportunity solicited ideas to
Introduction Fragment-based drug design (FBDD) uses molecular fragments to identify
Introduction Inhibiting Protein-Protein Interactions (PPIs) with small molecules is
On Tuesday, October 1, PolarisQB hosted a webinar titled "Find
OpenFold, a leading non-profit artificial intelligence (AI) research consortium focused on
PolarisQB is happy to announce the integration of Virtual Libraries and
Quantum-Aided Drug Design (QuADD) is delivering value to our customers
On Friday, May 17, PolarisQB hosted a group of thought
POLARISqb, a company revolutionizing drug design by joining quantum computing
POLARISqb, the first company to build quantum-enabled molecular optimization tools
Polaris Quantum Biotech (PolarisQB), the leader in quantum computing-based drug
The Defense Advanced Research Project Agency (DARPA) awarded POLARISqb a
PolarisQB, the first company in the world to develop a drug
At Polaris Quantum Biotech, we’re leveraging quantum computing to accelerate drug discovery.
PolarisQB, an industry leader in accelerating drug discovery using quantum computing,
As around 345.2 million people worldwide are predicted to be food
POLARISqb was recently the runner up in the Soy Innovation Challenge,
Aquafeed.com talked with PolarisQB, a company that is developing a feed additive
The scientists at POLARISqb designed and engineered the first drug discovery engine built
